By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CellCentric Ltd. 

Highfield Court
Church Lane
Madingley  Cambridge  CB3 8AG  United Kingdom
Phone: 44-0-1954-213498 Fax: 44-0-1954-213495



Start Up

Company News
CellCentric Ltd. Selects Sygnature Discovery (Formerly known as Sygnature Chemical Services) for Epigenetic Prostate Cancer Program 9/9/2013 9:35:58 AM
CellCentric Ltd. and ZoBio Enter into Partnership to Develop Lead Compounds Against Epigenetic Drug Targets 6/20/2012 10:06:59 AM
CellCentric Ltd. Licenses Novel Epigenetic Discovery Program to Takeda Pharmaceutical Co. Ltd. (TKDG.DE) (JOBS); Deal Could be Worth Excess of $200 Million 2/23/2010 10:11:29 AM
CellCentric Ltd. Secures 25th Epigenetics Academic Agreement 4/21/2009 1:25:33 PM
CellCentric Ltd. Expands its Leadership Team 2/4/2009 2:08:09 PM
CellCentric Ltd. and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Collaborate on Epigenetic Programme 1/6/2009 1:04:31 PM
Cenix BioScience GmbH and CellCentric Ltd. Second RNAi-Based Target Validation Project 7/1/2008 2:10:33 PM
Following Success of Pilot, Cenix BioScience GmbH Takes on Second RNAi-Based Target Validation Project for CellCentric Ltd. 7/1/2008 10:08:06 AM
Cenix BioScience GmbH and CellCentric Ltd. Sign Framework Research Agreement for RNAi-Based Target Validation 3/20/2008 8:44:55 AM
CellCentric Ltd. and Cancer Research Technology Collaborate on Epigenetic Discoveries 11/14/2007 12:24:47 PM